Emcee, Emmy Award Winning Broadcaster
Director of Communications & Media Technologies, Academy of Art University
Jan Yanehiro co-hosted Evening Magazine, a nightly television program in San Francisco that ran for 15 years on KPIX TV-CBS5. The show pioneered the use of video and is often cited as the show that launched entertainment and reality programming. Yanehiro traveled the world in search of exotic places and fascinating celebrities.
She has bungee jumped, sky dived with the Army’s Golden Knights and climbed
a frozen waterfall in Colorado. Currently, she is the Founding Director of the School of Communications and Media Technologies at the Academy of Art University in San Francisco. She has hosted 6 documentaries on the US Government internment of 110,000 Japanese Americans during World War II. Yanehiro has won multiple awards including an Emmy, the Eleanor Roosevelt Humanitarian Award and the Girl Scout’s Woman of Distinction. She is Board Chair of The Representation Project and holds seats on Kristi Yamaguchi’s Always Dream Foundation and the US-Japan Council. Yanehiro graduated from Fresno State University, Fresno, California, with a BA degree in Journalism. She is the author of three books, her latest is, This Is Not The Life I Ordered…50 Ways To Keep Your Head Above Water When Life Keeps Dragging You Down.
Dr. Pamela Munster
Keynote Speaker & Visionary Award Recipient
Program Leader, Developmental Therapeutics
Director, Early Phase Clinical Trials
Co-director, Center for BRCA Research
Professor in Residence
Division of Hematology/Oncology
Department of Medicine
Dr. Munster received her medical degree from the University of Bern, Switzerland; completed her residency in Internal Medicine at Indiana University Medical Center then moved to Memorial Sloan- Kettering Cancer Center, New York for her oncology and hematology fellowship. She served at Memorial Sloan Kettering as a faculty member in the breast cancer program before joining the Division of Breast Oncology and Experimental Therapeutics Program at Moffitt Cancer Center and Research Institute, in
Tampa, Florida. Dr. Munster led the group as the Scientific Director of Breast Research and Co-Chair of the Phase I Program at Moffitt for six years prior to joining the University of California in San Francisco. Currently Dr. Munster is Professor in Residence at the University of California, San Francisco, where she is also the Director of Early Phase Clinical Trials Program at the Helen Diller Family Comprehensive Cancer Center and Program Leader of Experimental Therapeutics. Dr. Munster is Co-Director of the
Center for BRCA Research, a BRCA-focused clinical and research program at the Helen Diller Family Comprehensive Cancer Center at UCSF.
Dr. Munster is the principle investigator of a research lab focused on developing novel targeted therapy for the treatment of treatment resistant cancer and their integration into current treatment strategies. The lab involves basic research studies on epigenetic modification of DNA repair and therapy resistance. Her laboratory is involved in several projects testing HDAC inhibitors reverse hormone therapy resistance in breast cancer and to reengage the immune defense. Over the recent years, her team has been developing new devices to selectively deliver anticancer agents to those at risk for cancer with the goal to prevent cancers in high risk individuals.
She is the lead investigators on several clinical trials involving early drug development for cancer, serves on NIH/NCI study sections and leads international cancer awareness campaigns on breast cancer and cervical cancer. Dr. Munster has published in numerous scientific journals and has given ectures on early drug development, breast cancer, clinical trials and translational research and is a strong advocate for patients with cancer germ line mutations. Intending to share the hope and incredible advances in research with the broader community, she describes her journey of developing the disease in which she is an expert in her new book, Twisting Fate. As a carrier of one of the most feared cancer mutations, she provides a glimpse into the medical and emotional turmoil of breast and other cancers related to the BRCA mutation. She takes the reader through the different stages of cancer, bringing to life the voices of patients, family members and
friends living with this disease. With a unique view through both a professional and personal lens, she shows that knowing about a genetic mutation can change the lives of the entire family and spare future generations.
Dr. Elieen Consorti
Visionary Award Recipient
Alta Bates Summit Medical Center
Dr. Consorti is medical director for the Carol Ann Read Breast Health Center at Alta Bates Medical Center, and an oncologic surgeon with Sutter East Bay Medical Foundation. She received her medical degree from the Loyola Stritch School of Medicine in Chicago, and completed her residency at the University of Minnesota at Minneapolis and the University of Texas at Houston and she did a fellowship at M.D. Anderson Cancer Center, in Houston. Dr. Consorti is specially trained in the INTRABEAM™ intraoperative radiation therapy (IORT) system.
Stanford University, School of Medicine
Dr. Melinda Telli is an Associate Professor of Medicine in the Division of Medical Oncology at Stanford University School of Medicine and Leader of the Breast Oncology Clinical Research Group at the Stanford Cancer Institute. Dr. Telli’s research focuses on the development of novel therapies for the treatment of triple-negative and hereditary cancer. Her work has focused on the validation of homologous recombination deficiency biomarkers to help identify patients with sporadic triple-negative breast cancer that may specifically derive benefit from platinum chemotherapy. In addition to her involvement in the clinical development of PARP inhibitors for BRCA1 and BRCA2 mutation-associated cancers, she has also explored the use of beyond BRCA’ DNA repair gene mutations as potential biomarkers to select patients for PARP inhibitor therapy in the advanced disease setting.
Dr. Telli received her undergraduate degree from the University of Pennsylvania Magna Cum Laude and medical degree from George Washington University with Distinction. She completed internship and residency in Internal Medicine at Stanford University, and then stayed at Stanford to pursue fellowship training in Medical Oncology. She has served on numerous American Society of Clinical Oncology Committees and currently serves as a Komen Scholar and as a member of the National Comprehensive Cancer Network Breast Cancer Guideline Panel. Dr. Telli is the recipient of a Susan G. Komen for the Cure Translational Postdoctoral Fellowship Award (2008), American Society of Clinical Oncology Young Investigator Award (2009), Susan G. Komen for the Cure Leadership Award (2015 and 2018) and Triple Negative Breast Cancer Foundation Hero Award (2018). She has garnered multiple teaching accolades is a repeat recipient of the Stanford Division of Oncology Teaching Award.
Considered the founder of the industry, Genentech, now a member of the Roche Group, has been delivering on the promise of biotechnology for over 40 years. Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes medicines to treat patients with serious or life-threatening medical conditions. We are among the world's leading biotech companies, with multiple products on the market and a promising development pipeline.
Genentech believes it’s urgent to deliver medical solutions right now – even as they develop innovations for the future. They are passionate about transforming patients’ lives and are courageous in both decision and action. And we believe that good business means a better world. Genentech is committed to scientific rigor, unassailable ethics, and access to medical innovations for all, with a goal of building a better tomorrow.
Philanthropist Award Recipient
Board of Trustees, National Public Radio
Power of Choice Leadership Council, San Francisco
Anette L. Harris, M.A. is a member of the Board of Trustees of
NPR (National Public Radio) and serves on the Power of Choice
Leadership Council in San Francisco. She served over 10 years
as a member of the Board of Governors of the San Francisco
Symphony. In 2000, Anette was elected as the first African-American President of the Junior League of San Francisco in its 90-year history. She is the chair of San Francisco Achievers Advisory Council, and has also raised funds for Macy's Passport, City College of San Francisco, and the Breast Cancer Emergency Fund. In 2016 Anette Harris was recognized at Women At The Center Honors (WATCH) by the Junior League of San Francisco.
Mario Diaz, Wells Fargo Bank
Vice President, Community Relations
Wells Fargo Bank
Patrick Barber, Compass
Susan G. Komen San Francisco Bay Area Affiliate President, Board of Directors
Patrick V. Barber is president of Pacific Union International, Inc. He serves on the executive committee of the company and contributes to the strategic direction, long-term planning, and fiscal decision-making processes of the expanding brokerage. Barber joined the Pacific Union team in March 2010 after 12 years at Sotheby's International Realty. At Pacific Union, Barber's focus is on strategic growth and operations, agent development, marketing, and community efforts. Passionate about client service, Barber understands the cyclical challenges of selling real estate in California and how to navigate complex transactions. His ability to find and nurture agent talent has become his hallmark at the brokerage. As one of the top 10 real estate firms in the U.S. Pacific Union has developed impactful international reach, and delivered sales volume of $14.1 billion in 2017. The brokerage was named World’s Best brokerage 2017-2018 with over 20 offices, by the prestigious London-based International Property Awards.
A native San Franciscan, Barber is deeply committed to the region in which he lives and works. He is the past president for the San Francisco Association of Realtors, has served on the executive committee for the California Associate of Realtors, and is president of the local Susan G. Komen affiliate. In addition, he is a founder and past president of San Francisco's Encore and a former associate trustee of the San Francisco Ballet. Over the years, Barber has been a supporter of: Headland for the Arts; the California Academy of Sciences; the Family Arts Circle for the De Young and Legion of Honor museums; a Young Collector for Enterprise for High School Students; and a member the Chairman's Circle of the SFMOMA; San Francisco Opera's Bravo; the Asian Art Museum; the San Francisco Zoo; the Bay Area Discovery Museum and he was former chairman and president of the Bachelors of San Francisco.
Pam Judd Award for Volunteerism
For questions, please contact Teddy Reich at firstname.lastname@example.org
2019 Visionary Awards Luncheon
February 22, 2019
Julia Morgan Ballroom
465 California St, San Francisco, CA 94104
11:00 Reception & Silent Auction
12:00 Luncheon and Program
The San Francisco Bay Area Affiliate of Susan G. Komen®
The San Francisco Bay Area Affiliate of Susan G. Komen® is dedicated to combating breast cancer at every front. Up to 75 percent of the Affiliate’s net income goes toward funding grants to local hospitals, clinics and community organizations that provide breast health education and breast cancer screening and treatment programs for medically underserved women. The remaining net income (a minimum of 25 percent) supports the national Komen Grants Program, which funds groundbreaking breast cancer research, meritorious awards and educational and scientific programs around the world.
Komen SF Bay Area has the distinction of being the very first Affiliate of Susan G. Komen ®. Our Affiliate was founded by Joanne Horning, and her husband Rick, in honor of Joanne’s mother’s battle against breast cancer.
Komen SF Bay Area’s service area covers eight Bay Area counties of Sonoma, Napa, Marin, San Francisco, Alameda, Contra Costa, San Mateo, and Santa Clara. Thanks to the thousands of people who participate in the Komen San Francisco Race for the Cure® and other Affiliate events each year, dedicated corporate partners and generous donors, Komen San Francisco is playing a vital role in fighting breast cancer in our community.
Susan G. Komen San Francisco Bay Area Affiliate
1469 Pacific Avenue, San Francisco CA 94109
Or visit us online at KomenSF.org